logo
OceanTech Acquisition I Corp. (OTEC) Sells Sponsor Shares
by Marlena Haddad on 2023-03-13 at 6:23pm

OceanTech Acquisition I Corp. (NASDAQ:OTEC) announced this afternoon that it has entered into a purchase agreement with its sponsor, OceanTech Acquisitions I Sponsors, and a new sponsor, Aspire Acquisition. As a result, OceanTech will undergo a change in management.

Under the agreement, the new sponsor will purchase 2,581,500 shares of Class B common stock from the original sponsor and 5,869,880 private placement warrants, each of which is exercisable to purchase one share of Class A common stock of OTEC for an aggregate purchase price of $1 payable at the time the SPAC completes a merger.

Upon the closing of a business combination, Aspire Acquisition will also convey 250,000 shares of Class B Common Stock and 250,000 private placement warrants to the equity holders of the original sponsor, as of the effective date, pro rata based on the original sponsor equityholders’ underlying interest in OTEC’s Class B Common Stock.

Upon the closing of the agreement, Aspire will reimburse $25,000 to former director Joseph Adir, and pay the former CEO of OTEC Charles Baumgartner $5,000 per month during the transition period.

In addition to the payment of the purchase price, Aspire also assumes responsibility for all of OTEC’s reporting obligations and all other obligations of the original sponsor related to the company.

Following the purchase agreement, OceanTech’s management will be replaced with personnel selected by the new sponsor.

Suren Ajjarapu was appointed as the new CEO and Chairman, who has served as a director of the company since 2021. Mr. Ajjarapu has also served as Chairman of the Board, CEO and Secretary of Trxade Group, Inc., (NASDAQ: MEDS), and its predecessor company. Previously, Mr. Ajjarapu served as CEO and Chairman of Aesther Healthcare Acquisition Corp., a SPAC that completed a business combination with Ocean Biomedical (Nasdaq:OCEA) in February 2023. Mr. Ajjarapu is currently serving as a director of the merged company.

Frank Knuettel II was appointed as the company’s new CFO, bringing over 25 years of management experience in venture and private-equity backed public companies. Mr. Knuettel served as the CEO and director of Unrivaled Brands (OTCQX:UNRV) (f/k/a Terra Tech Corp. (OTCQX:TRTC)), a vertically integrated company focused on the cannabis sector with operations in California and Nevada.

Joseph Adir, Michael Payne, Eric Blair, Mitchell Gordon, Charles Baumgartner, Ofer Oz, and Ken Hickling tendered their resignations as directors and officers of the company. Taking their place will be Michael Peterson, Donald Fell, Venkatesh Srinivasan, and Siva Saravanan as new members of the board of directors.

The selling of OceanTech’s sponsorship comes less than a month after the SPAC mutually terminated its $333.3 million merger with Majic Wheels Corp. in February.

But, that wasn’t the first deal OceanTech I terminated. It originally announced a combination with biotech firm Captura Biopharma in August 2022. It divulged little information on this transaction at the time, other than Captura was developing treatments for radiation and other heavy-metal poisonings.

It then terminated the deal just two months later in October 2022 for undisclosed reasons, before announcing a deal with Majic.

OceanTech recently disclosed that it intends to continue its search for an alternative target to combine with and has a completion deadline of April 2.

 

Recent Posts
by Nicholas Alan Clayton on 2024-10-08 at 8:23am

At the SPAC of Dawn The SPAC world is set to get its newest member later today when Launch Two (NASDAQ:LPBBU) begins trading having priced its $200 million IPO overnight. The technology SPAC is the first to IPO this quarter and comes after the newfound SPAC issuance momentum appeared to throttle down slightly in September,...

by Nicholas Alan Clayton on 2024-10-07 at 5:48pm

Launch Two Acquisition Corp. announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “LPBBU”, Tuesday, October 8, 2024. The new SPAC’s primary search focus will be on technology and software infrastructure companies whose products and services target financial services, real estate and...

by Nicholas Alan Clayton on 2024-10-07 at 12:34pm

Oaktree III Life Sciences (NASDAQ:OACCU) has filed for a $175 million SPAC with some of the most aggressively team-friendly terms seen so far in the second half of 2024. The new SPAC’s units contain 1/5 warrants and the trust is not set to be overfunded. Only the warrantless Cantor Equity Partners (NASDAQ:CEP) has IPO’d so...

by Nicholas Alan Clayton on 2024-10-07 at 8:25am

At the SPAC of Dawn SPACs are set to have a sleepy start to their post-Rosh Hashanah week with no votes on the docket until Wednesday. Three SPACs are to hold extension votes that day and Clover Leaf (OTC:CLOE) will try again to close its combination with Kustom Entertainment after several adjournments on Friday. In...

by Kristi Marvin on 2024-10-05 at 10:00am

Terms Tracker for the Week Ending October 4, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. This week was much, much heavier on the S-1 filings. There were five new SPACs filed along with six amended S-1 registration statements making good...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved